Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Selpercatinib is a drug that targets mutations in the RET gene and is suitable for a variety of cancers caused by RET fusions or mutations. It stops the growth and spread of tumors···【more】
Article source：Captain MedicineRelease date：2024-08-19Recommended：419
In 2020, Selpercatinib was approved by the FDA as the first highly selective RET inhibitor for the treatment of a variety of cancers caused by RET gene fusions and mutations. It ef···【more】
Article source：Captain MedicineRelease date：2024-08-19Recommended：492
In May 2020, Selpercatinib received FDA approval as a breakthrough drug for the treatment of RET gene fusion and mutant cancers. It is especially suitable for adult and pediatric p···【more】
Article source：Captain MedicineRelease date：2024-08-19Recommended：498
As a novel anti-cancer drug, Selpercatinib can treat solid tumors associated with RET gene mutations. By interfering with key signaling pathways of cancer cells, it effectively slo···【more】
Article source：Captain MedicineRelease date：2024-08-19Recommended：531
Selpercatinib is a targeted drug designed for the treatment of non-small cell lung cancer, targeting RET gene mutations, and the mechanism of action is to limit the spread of cance···【more】
Article source：Captain MedicineRelease date：2024-08-19Recommended：518
Mitotanecan inhibit the function of adrenal cortical cells, especially the activity of core cholesterol side-chain lyase, which can precisely block the synthesis of steroid hormone···【more】
Article source：Captain MedicineRelease date：2024-08-19Recommended：448
Mitotaneworks primarily by inhibiting the function of adrenal cortical cells. It can inhibit cholesterol side-chain lyase, a key enzyme in steroid hormone synthesis, thereby reduci···【more】
Article source：Captain MedicineRelease date：2024-08-19Recommended：544
Mitotaneis a medication used to treat specific types of cancer and adrenal gland-related disorders.What is the recommended dosage of Mitotane?The clinically recommended dose of Mit···【more】
Article source：Captain MedicineRelease date：2024-08-19Recommended：577
Selpercatinib blocks tumor growth and spread by inhibiting the kinase activity of the RET fusion protein. As a targeted drug, it has been used to treat a variety of cancer types as···【more】
Article source：Captain MedicineRelease date：2024-08-16Recommended：472
Selpercatinib is an innovative RET inhibitor specifically designed to treat cancers associated with RET gene mutations. By interfering with the signaling pathways of cancer cells, ···【more】
Article source：Captain MedicineRelease date：2024-08-16Recommended：535
Selpercatinib is a highly selective RET inhibitor that inhibits the growth of tumor cells by blocking RET kinase activity. In May 2020, the FDA approved the drug for use as an impo···【more】
Article source：Captain MedicineRelease date：2024-08-16Recommended：460
Selpercatinib is the first targeted drug specifically targeting RET gene mutations and was approved by the FDA in 2020; By inhibiting the activity of RET kinase and blocking the gr···【more】
Article source：Captain MedicineRelease date：2024-08-16Recommended：426
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended：8532025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended：10502024-09-07
Recently, Lao Lucius Pharmaceutical (Lucius Pharmaceuticals) issued a solemn statement regarding cou···【more】
Recommended：3032026-10-10
Lucius Pharmaceuticals Version of Vibegron Now Available1.Basic Drug InformationVibegron (generic na···【more】
Recommended：4052026-06-08
In recent years, leveraging the World Trade Organization (WTO) patent waiver for least-developed cou···【more】
Recommended：5962026-05-08
How Can Chinese Patients Access Generic Drugs from Laos?In recent years, generic drugs from Laos hav···【more】
Recommended：5682026-04-08
Lucius Pharmaceuticals version of Ibrutinib is now availableIn a randomized controlled trial of 269 ···【more】
Recommended：4542026-03-08
Leveraging the WTO patent waiver for least-developed countries (extended to 2033), Laos has seen rap···【more】
Recommended：6052026-31-07
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address: No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Name: Lucius
Telegram name: Vira
No.:0085253923643
Telegram name: Vira
No.:0085253923643
